Journal of Heart and Lung Transplantation
-
Publication Venue For
-
Distal vessel pulmonary thromboendarterectomy: Results from a single institution
2023
-
Bridging the translation gap in cytomegalovirus therapeutics through ex vivo lung perfusion: Opportunities and challenges..
41:298-299.
2022
-
Plasma kallikrein predicts primary graft dysfunction after heart transplant..
40:1199-1211.
2021
-
Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis..
40:642-651.
2021
-
Risk of severe primary graft dysfunction in patients bridged to heart transplantation with continuous-flow left ventricular assist devices..
37:1433-1442.
2018
-
Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation..
36:1226-1233.
2017
-
Clinical Predictors and Outcome Implications of 30-Day Hospital Readmission in Lung Transplant Recipients.
32:S265-S266.
2013
-
Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era..
32:106-111.
2013
-
Risk assessment in pulmonary hypertension associated with heart failure and preserved ejection fraction.
31:467-477.
2012
-
Erratum:Exercise blood pressure response during assisted circulatory support: Comparison of the total artifical heart with a left ventricular assist device during rehabilitation (Journal of Heart and Lung Transplantation (2011) 30:11 (1207-13)).
31:113.
2012
-
Cardiac calcitonin gene–related peptide and left ventricular hypertrophy in the cardiac allograft.
29:487-488.
2010
-
235: Increased Resource Utilization and Financial Costs of Lung Transplantation after Implementation of the Lung Allocation Score.
28:S148-S148.
2009
-
198.
25:S112-S112.
2006
-
366.
25:S169-S170.
2006
-
Neointimal inflammation and adventitial angiogenesis correlate with severity of cardiac allograft vasculopathy in pediatric recipients..
24:1039-1045.
2005
-
Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients..
24:S255-S261.
2005
-
Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study..
24:S249-S254.
2005
-
Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study..
24:S249-S254.
2005
-
Pulmonary embolization of microcrystalline cellulose in a lung transplant recipient..
24:624-627.
2005
-
12 month report of a 3 arm multicenter comparison of Tacrolimus (TAC), MMF or TAC/Sirolimus(SRL) and steroids vs Cyclosporine microemulsion(CYA), MMF and steroids in de novo cardiac transplant recipients.
24:S61-S62.
2005
-
Intracardiac transplantation of a mixed population of bone marrow cells improves both regional systolic contractility and diastolic relaxation..
24:205-214.
2005
-
Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vessels..
23:666-673.
2004
-
Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin..
23:317-322.
2004
-
Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers..
22:1141-1148.
2003
-
The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure..
22:70-77.
2003
-
Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation..
21:1127-1130.
2002
-
Prognostic value of serum carcinoembryonic antigen levels in patients who undergo lung transplantation..
20:1305-1309.
2001
-
Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection..
18:819-827.
1999
-
Dobutamine stress echocardiography: experience in pediatric heart transplant recipients..
18:725-732.
1999
-
Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds..
18:470-477.
1999
-
Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents..
17:1029-1033.
1998
-
Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease..
17:789-794.
1998
-
Right ventricular function in orthotopic total atrioventricular heart transplantation..
17:826-834.
1998
-
Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension..
17:669-678.
1998
-
Prevention of ischemically induced neointimal hyperplasia using ex vivo antisense oligodeoxynucleotides..
17:349-355.
1998
-
An adult canine model of chronic pulmonary hypertension for cardiopulmonary transplantation..
16:538-547.
1997
-
The combined effects of brain death and cardiac graft preservation on cardiopulmonary hemodynamics and function before and after subsequent heart transplantation..
15:764-777.
1996
-
Immunologic barriers to xenotransplantation..
15:547-555.
1996
-
Myocardial acoustics in pediatric allograft rejection..
15:596-604.
1996
-
Total pulmonary artery occlusion immediately after lung transplantation: successful revascularization with intravascular stents..
15:532-535.
1996
-
Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients..
15:206-217.
1996
-
Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease..
15:67-77.
1996
-
Influence of gender on allograft rejection in a rat heart transplant model..
14:529-536.
1995
-
Load-independent analysis of a pulsatile right ventricular assist device..
14:177-185.
1995
-
Management of biliary complications after heart transplantation..
14:623-631.
1995
-
Natural antipig xenoantibody is absent in neonatal human serum..
14:749-754.
1995
-
Stability of the beta-adrenergic receptor/adenylyl cyclase pathway of pediatric myocardium after brain death..
13:635-640.
1994
-
Improved tolerance of the pediatric myocardium to brain death.
12.
1993
-
A new rat infection-heart transplant model: effect of infection on graft survival studies..
12:659-664.
1993
-
Antibody formation after drug administration during cardiac surgery: parameters for aprotinin use..
12:S26-S33.
1993
-
Effects of triiodothyronine and vasopressin on cardiac function and myocardial blood flow after brain death.
12:68-80.
1993
-
Effects of triiodothyronine and vasopressin on cardiac function and myocardial blood flow after brain death..
12:68-79.
1993
-
Improved tolerance of the pediatric myocardium to brain death..
12:S236-S240.
1993
-
Pharmacologic reduction of pretransplantation pulmonary vascular resistance predicts outcome after pediatric heart transplantation..
12:965-972.
1993
-
Spectrum of humoral rejection after pediatric heart transplantation..
12:563-571.
1993
-
Analysis of myocardial function in orthotopic cardiac allografts after prolonged storage in UW solution..
10:527-536.
1991
-
Erratum: Efficacy and durability of central over sewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices (Journal of Heart and Lung Transplantation (2014) 33 (937-42)).
33:1202.
2014
-
Residual mitral regurgitation in patients with left ventricular assist device support - An INTERMACS analysis.
2022
-
A 20-Year Retrospective Analysis Shows Differential Predictors in Lung Procurement Between DCD and DBD Donors
2022
-
Bronchoalveolar Lavage Fluid (BALF) as a Compartment for DonorDerived Cell-Free DNA (dd-cfDNA) Assessment in Lung Recipients
2022
-
COVID-19 in Lung Transplant Recipients: Outcomes and Long-Term Follow Up
2022
-
Case Report of Donor Transmitted SARS-CoV-2 Infection During Lung Transplantation
2022
-
Comparing the Paragonix LUNGguard Donor Lung Preservation System to Traditional Ice Storage
2022
-
Delphipanel on Antimicrobial Stewardship and Management of Clinical Syndromes in Thoracic Organ Transplants and Mechanical Circulatory Device Recipients
2022
-
Diagnosis of Pulmonary Veno-Occlusive Disease in the Absence of Hemodynamic Abnormalities
2022
-
Efficacy and Safety of the Janus Kinase 1 Inhibitor Itacitinib (ITA) in Patients with Bronchiolitis Obliterans (BOS) Syndrome Following Double Lung Transplant
2022
-
Extended Cold Preservation Times Are Not Associated with Increased Post-Transplant Mortality After Ex Vivo Lung Perfusion (EVLP) at a Dedicated Facility Using a Centralized Lung Evaluation System (CLES)
2022
-
First US DCD Pediatric Heart Transplant Using Ex-Vivo Perfusion: Is It Time for a Clinical Trial?
2022
-
Gastroparesis Following Lung Transplant: A Single Center's Experience
2022
-
Increasing Lung Transplant Availability with Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated Facility and a Centralized Lung Evaluation System (CLES): 3-Year Outcomes
2022
-
Intra-Tracheal Adeno-Associated Virus Mediates Gene Transduction During Static Cold Storage in Rodent Lung Transplantation
2022
-
Is Acute Rejection Truly Acute or an Exacerbation of an Underlying Disease?
2022
-
Long-Term Results of the OCS Lung Expand International Trial Using Organ Care System Lung Perfusion System (OCS) in Extended-Criteria Donor (ECD) and Donation After Circulatory Death (DCD) Donor Lungs
2022
-
Normothermic Ex Vivo Lung Perfusion (Novel) as an Assessment of Extended Criteria Donor Lungs: A Prospective Multi-Center Clinical Trial
2022
-
Obesity Does Not Significantly Impact Operative and Long-Term Outcomes After Pulmonary Thromboendarerectomy
2022
-
Performance of Donor-Derived Cell-Free DNA (dd-cfDNA) for Discriminating Acute Lung Allograft Injury in a Multicenter Cohort
2022
-
Proteomic Profiling of Cold Storage Preservation Solution to Identify Signatures of Primary Graft Dysfunction Following Heart Transplantation
2022
-
Report of the GUARDIAN-LUNG Registry: An Analysis of Advanced Hypothermic Preservation on Lung Transplantation
2022
-
Transplanting Thoracic COVID-19 Positive Donors: Overcoming the Pandemic
2022
-
Trends in Substance Use in Patients Requiring Advanced Heart Failure Therapies
2022
-
A Multi-Center Study of CMV Prophylaxis Strategies in Intermediate Risk (R plus ) Heart Transplant Recipients
2021
-
A Multicenter Prospective Registry Study of Lung Transplant Recipients Hospitalized with COVID-19
2021
-
A Novel Post-Transplant Multimodal Antibody Management Protocol for Highly Sensitized Lung Transplant Recipients
2021
-
A Rare Case of Symmetrical Cutaneous Alternaria Infections after Bilateral Lung Transplant
2021
-
Acute Cellular Rejection in Lung Transplant: Can the Bronchoscopist Assess Transbronchial Biopsy Sample Adequacy?
2021
-
Association between Pulmonary Hypertension and Outcomes in Heart-Kidney Transplantation
2021
-
Bronchoalveolar Bile Acids are Associated with Acute Rejection, Inflammation, and Allograft Survival: A Multi-Center Study
2021
-
Cardiac Allograft Injury in Patients of African Ancestry: Trends of Donor-Derived Cell-Free DNA Based on Genetic Ancestry
2021
-
Challenges in Lung Re-Transplantation Following Antibody-Mediated Rejection
2021
-
Decreased Utilization of Durable Left Ventricular Assist Device Therapy in Blacks Relative to Whites with Advanced Heart Failure
2021
-
Effect of Surgical Exposure on Outcomes in Lung Transplantation: Insight from the International Multicenter Extracorporeal Life Support (ECLS) in Lung Transplantation Registry
2021
-
Efficacy of 3 Months vs. 6 Months of Valganciclovir Prophylaxis for Heart Transplant Recipients at Intermediate Risk (R plus ) for CMV Complications
2021
-
Extracorporeal Life Support Registry: Analysis of Ex Vivo Lung Perfusion Utilization in Donor after Cardiac Death and Donor after Brain Death
2021
-
False Positive Hepatitis C Virus Serologies in Pediatric Patients with Left Ventricular Assist Devices
2021
-
Impact of Cold Ischemic Time on Morbidity and Mortality after Lung Transplantation. An Updated Analysis of the International Multicenter Extracorporeal Life Support in Lung Transplantation Registry
2021
-
Inhaled Selective Pulmonary Vasodilators for Adult Lung Transplantation
2021
-
Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies
2021
-
Interim Results - The Effect of Donor Type (Donor after Cardiac Death vs Donor after Brain Death) and Use of Intraoperative Extracorporeal Lung Support on Survival after Lung Transplantation
2021
-
Percutaneous Coronary Interventions in Patients Supported with Left Ventricular Assist Devices
2021
-
Perioperative Acute Kidney Injury after Sequential Bilateral Lung Transplant: Comparing Intraoperative Elective VA ECMO to an "Off Pump" Strategy
2021
-
Predicting PGD after Lung Transplantation
2021
-
Proteomic Profiling of Heart Transplant Recipients Identifies CLE4C Expression as a Novel Biomarker of Primary Graft Dysfunction
2021
-
Rising PGD Incidence Parallels Increased Recipient Disease Severity
2021
-
The Pulmonary Microbiome after Lung Transplantation is Associated with Gastroesophageal Reflux Disease, Inflammation, and Allograft Dysfunction
2021
-
Transfusion Requirements during Lung Transplantation: Elective VA ECMO vs. Off-Pump
2021
-
Acute Rejection (AR) and Lymphocytic Bronchiolitis (LB) in a Multicenter Lung Transplant Cohort
2019
-
Anticoagulation Strategies in the Perioperative Period for Lung Transplant: 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal
2019
-
Center Variability in Organ Offer Acceptance and Waitlist Mortality in Lung Transplantation
2019
-
Donation after Circulatory Death in Heart Transplantation May Increase the Donor Pool by 20% in the U.S
2019
-
Effects of Nissen Fundoplication on Markers of Microaspiration and Inflammation after Lung Transplantation
2019
-
Gender Disparity in Left Ventricular Assist Device Utilization: Insights from Nationwide Inpatient Sample 2004-2016
2019
-
Heart Transplantation Survival and the Use of Traumatically Brain-Injured Donors
2019
-
HeartMate 3 Surgical Implant Technique and Outcomes in the MOMENTUM 3 Trial
2019
-
Hepatitis and Thoracic Transplantation - No More Virus Non-Grata
2019
-
High Calculated Panel Reactive Antigen (cPRA) is Associated with Decreased Rates of Transplantation and Increased Waitlist Mortality in Lung Transplantation: A UNOS/OPTN Registry Analysis
2019
-
Host miRNA Profile of Aspergillus Colonization Resulting in CLAD in Lung Transplant Recipients
2019
-
Host miRNA Profile of Invasive Aspergillosis in Lung Transplant Recipients
2019
-
ISHLT Consensus on Standardization of Bronchoalveolar Lavage in Lung Transplantation
2019
-
Impact of Respiratory Syncytial Virus Infection on Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients
2019
-
Improvements in Health-Related Quality of Life with Lung Transplantation: A Prospective Multicenter Cohort Study
2019
-
Increase in Donor Fraction Cell-Free DNA Correlates with Cellular and Antibody Mediated Rejection (ACR/AMR) in Adult and Pediatric Heart Transplant Recipients: DNA Based Transplant Rejection Test (DTRT)-A Prospective Blinded Multicenter NIH/NHLBI Funded Clinical Study
2019
-
Increase in Total Cell-Free DNA Correlates with Death in Adult and Pediatric Heart Transplant Recipients: DNA Based Transplant Rejection Test (DTRT)-A Prospective Blinded Multicenter NIH/NHLBI Funded Clinical Study
2019
-
LVAD Patients with RV Failure Pre-Heart Transplant Have Reduced Post-Transplant Survival
2019
-
Long (> 6h) versus Short (< 6h) Clinical Normothermic Ex-Vivo Portable Lung Preservation: Post-Hoc Analysis of OCS Lung EXPAND Trial
2019
-
Lung Bile Acid as Biomarker of Microaspiration and Its Relationship to Lung Inflammation
2019
-
Lung Transplantation from Donation after Circulatory Death Donors Following Portable Ex-Vivo Lung Perfusion: Post-Hoc Analysis of OCS Lung EXPAND Trial
2019
-
Mitigating the Impact of Gender Mismatch in Heart Transplantation Using BMI and BSA Ratios
2019
-
Occurrence and Risk Factors for Acute Lung Injury (ALI) and Organizing Pneumonia (OP) after Lung Transplant
2019
-
Older Donors Portend Worse Survival in Older and Younger Recipients after Heart Transplant: A UNOS Database Analysis
2019
-
Predicting Survival for Lung Retransplantation Patients at One and Five Years
2019
-
Risk Stratification of Inotropic Therapy for Heart Transplant Candidates in the Era of Ventricular Assist Device Support
2019
-
Successful Utilization of Extended Criteria Donor (ECD) Hearts for Transplantation - Results of the OCS™ Heart EXPAND Trial to Evaluate the Effectiveness and Safety of the OCS Heart System to Preserve and Assess ECD Hearts for Transplantation
2019
-
The Role of Transpulmonary Gradient and Mean Pulmonary Artery Pressure in Risk Stratification of Heart Transplant Candidates with Pulmonary Hypertension
2019
-
Time from Lung Transplant Donor Brain Death to Cross Clamp: An Analysis of the UNOS Registry
2019
-
Unfavorable Donor after Cardiac Death Characteristics in Lung Transplantation: An Analysis of the UNOS Registry
2019
-
Adverse Events and Their Effect on Quality of Life and Functional Capacity in the ENDURANCE and ENDURANCE Supplemental Trials
2018
-
Blood Group O is Associated with Decreased Rates of Transplantation and Increased Waitlist Mortality in Lung Transplantation: A Propensity-Matched Registry Analysis
2018
-
Blood Pressure Management Ameliorates the Severity of Neurological Events
2018
-
Breaking the Viral Spiral: Changing how you C Hepatitis
2018
-
Brincidofovir - Finally an Option for PML?
2018
-
Bronchoalveolar Lavage Fluid Proteome in Chronic Lung Allograft Dysfunction
2018
-
CXCR4 Inhibition Improves Donor Leukocyte Depletion During Ex Vivo Lung Perfusion
2018
-
Does Center Volume Affect Failure to Rescue Rates in Lung Transplantation? A U.S. Nationwide Analysis
2018
-
Don’t Pass the Peanuts: Donor-Derived Nut Allergy in Lung Transplant
2018
-
Early Rhinovirus Infection After Lung Transplantation - Simply the Innocent Bystander?
2018
-
Effect of Heart Rate Reserve on Exercise Capacity in Patients Treated With a Continuous Flow Left Ventricular Assist Device: A Multicentre Study
2018
-
Hyaluronan in Acute Rejection After Lung Transplantation
2018
-
Impact of Ischemic Time on Primary Graft Dysfunction: A National Analysis
2018
-
Implications of the Refusal of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation
2018
-
Implications of the Refusal of Increased Risk Donor Offers on Waitlist Survival in Lung Transplantation
2018
-
Posterior Reversible Encephalopathy Syndrome After Lung Transplant: Clinical Characteristics and Outcomes
2018
-
Results of the OCS Lung EXPAND International Trial Using Portable Normothermic OCS Lung Perfusion System (OCS) to Recruit and Evaluate Extended Criteria Donor (ECD) Lungs
2018
-
Single Lung Transplantation in Patients with Severe Secondary Pulmonary Hypertension
2018
-
Socioeconomic Status Influences Outcomes for Patients Undergoing Heart Transplantation But Not LVAD Implantation
2018
-
Temporal Trends and Regional Variation in Multiple Listing among Lung Transplant Recipients in the United States
2018
-
The Effects of Concomitant Procedures at the Time of LVAD Implant for Patients in the ENDURANCE and ENDURANCE Supplemental Trials
2018
-
Ventricular Fibrosis and Other Factors Influencing Exercise Tolerance in LVAD Patients
2018
-
Advanced Therapy Utilization and Survival in Ambulatory Patients with Advanced Heart Failure: Results from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry
2017
-
Antibiotic Prophylaxis Strategies in LVAD Implantation and LVAD Infections: A Systematic Review of the Literature
2017
-
Automating the Diagnosis of Potential CLAD and Its Subtypes in Lung Transplant Recipients
2017
-
Depressive Symptoms and Post-Transplant Mortality: Examining the Influence of Perioperative Outcomes
2017
-
ENDURANCE Destination Therapy Trial Outcomes as Stratified by Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Classification
2017
-
Gene Expression Profiling of Bronchoalveolar Lavage Cells During Lung Allograft Acute Rejection
2017
-
Glad to Have a VAD Across Intermacs Profiles
2017
-
Impact of Diabetes Mellitus and Glycemic Control in Lung Transplant Donors on Recipient Survival
2017
-
Invasive Mycobacterium abscessus Infection in Heart Transplant Recipients
2017
-
Mycobacterium Abscessus Infection in Patients with Ventricular Assist Devices
2017
-
Natural History of Mitral Regurgitation After Left Ventricular Device Implantation: Should We Intervene on the Mitral Valve?
2017
-
Perceived Cognitive Difficulties and Quality of Life following Lung Transplantation
2017
-
Post-Transplant Lymphoproliferative Disorder After Lung Transplantation: 10-Year Experience at Duke University
2017
-
Predictors of Survival in Lung Transplant Recipients Requiring Post-Operative ECMO: First National Analysis
2017
-
Preoperative Functional Independence and Employment Status Are Associated with Improved Long Term Survival After Lung Transplantation
2017
-
Regulation of KLRG1 Gene Expression by T-bet Correlates with Human Cytomegalovirus-Specific CD8(+) T Cells Effector Function
2017
-
Simultaneous Heart-Kidney Transplantation Is Superior to Sequential Heart-Kidney Transplantation in Renal Failure Heart Transplant Candidates
2017
-
Simultaneous or Sequential Lung-Kidney Transplantation Confer Superior Survival in Renal-Failure Patients Undergoing Lung Transplantation: A National Analysis
2017
-
Slow Gait Speed Linked to More Severe Disease but Not with Early Events in Ambulatory Advanced Heart Failure: Results from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry
2017
-
Social Desirability Response Bias in Transplant Candidates' Self-Report of Psychosocial Variables
2017
-
The Effects of Patient Blood Pressure on the Occurrence of Serious Adverse Events in the ENDURANCE Trial
2017
-
The Epidemiology of Infection in MCS from the IMACS Database: January 2013 to December 2015
2017
-
The Impact of Age, Sex, Therapeutic Intent and Severity of Advanced Heart Failure on Outcomes in the Multicenter Study of Maglev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with Heartmate 3 (Momentum 3) Pivotal Trial
2017
-
The Impact of Intravenous Immunoglobulin in Sensitized Lung Transplant Recipients with a cPRA < 25%
2017
-
The Treatment of Patients with Advanced Heart Failure Ineligible for Cardiac Transplantation with the HeartWare Ventricular Assist Device: Results of the ENDURANCE Supplement Trial
2017
-
Underutilization of Lung Transplant Referral Among Patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF)
2017
-
A Novel Combined Endpoint Integrating Quality of Life Can Inform Decisions about VAD in Ambulatory Advanced Heart Failure
2016
-
Creating Standardized Reporting for Non-Rejection Lung Transplant Pathology to Improve Interobserver Agreement
2016
-
Depression, Quality of Life, and Mortality Early Following Lung Transplantation
2016
-
Does Single Lung Transplantation Change Perfusion in Relation to Native Lung in Pulmonary Fibrosis? Implications in Choosing Laterality
2016
-
Early Results of Biventricular Support with Durable, Intracorporeal Continuous Flow Centrifugal Ventricular Assist Devices: Analysis from INTERMACS
2016
-
Evaluation of an FVC-Based Definition of Restrictive Chronic Lung Allograft Dysfunction (CLAD) in a Multi-Center Cohort
2016
-
FVC and FEV1 Decline in Chronic Lung Allograft Dysfunction (CLAD) Phenotypes
2016
-
High Rates of Post-Transplant Depressive Symptoms Identified Using the CES-D
2016
-
Impact of Baseline Measures and Adverse Events on Functional Assessments in the ENDURANCE Destination Therapy Trial
2016
-
Implications of Amiodarone Use Before Heart Transplantation
2016
-
Incidence and Outcomes After Stroke on Rotary Flow Ventricular Assist Device Support
2016
-
Interim Results of a Phase II Clinical Trial Comparing Outcomes of Recipients of Lungs Recovered from Uncontrolled Donation After Circulatory Determination of Death Donors (uDCDDs) Assessed by Ex-Vivo Lung Perfusion (EVLP) and CT Scan to Outcomes of Recipients of Lungs from Brain-Dead Donors (BDDs)
2016
-
Interleukin 12-Dependent CMV-Specific CD4+ T Cell Proliferation, T-bet Induction and Effector Function During Primary Infection Are Key Determinants for Early Immune Control in Lung Transplant Recipients
2016
-
Intravenous Immunoglobulin in Sensitized Lung Transplant Recipients and Early Outcomes
2016
-
North American Experience with Biventricular HVAD Total Artificial Heart as a Successful Bridge to Orthotopic Heart Transplantation
2016
-
Physician Prediction of Outcomes in Ambulatory Patients with Advanced Heart Failure
2016
-
Plasma RIP3 Is Decreased in PGD after Lung Transplantation
2016
-
Pre-Extra Corporeal Membrane Oxygenation (ECMO) MELD Score May Predict Meaningful Survival
2016
-
Redefining Primary Graft Dysfunction after Lung Transplantation
2016
-
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients (ROADMAP) - 2 Year Results
2016
-
Soluble CD14 and LBP as Markers for Primary Graft Dysfunction
2016
-
Temporal Changes in Adverse Events in the ENDURANCE Trial
2016
-
The Positive Outcomes for Patients Receiving Animal Assisted Therapy after Lung Transplantation
2016
-
The Role of Loss-of-Function Mutations on Death and Development of Rejection in HTX/LTX Patients
2016
-
An Analysis of Early Versus Late Right Heart Failure With an Intrapericardial Continuous Flow LVAD
2015
-
CMV-Specific CD8+ T Cells Persist During Early Chronic Infection With Impaired Function and an EomeshiPD-1hi Exhausted Phenotype in Lung Transplant Recipients With Relapsing Viremia
2015
-
Cardiac Troponin I Levels in Preservation Solution Predict Primary Graft Dysfunction After Heart Transplant
2015
-
Clinical Prediction Model for PGD Among Patients With Pulmonary Hypertension
2015
-
Does the Utilization of a Temporary External Anchoring Suture Increase the Risk of Driveline Infection After Implantation of a Left Ventricular Assist Device
2015
-
Donor Hypernatremia Is an Independent Predictor of 1-Year Mortality Following Cardiac Transplantation
2015
-
Early Reassessment of Ambulatory Advanced Heart Failure Detects High-Risk Trajectories Along a Dynamic Baseline
2015
-
Factors Predicting Survival in Early Lung Retransplantation
2015
-
Functional and Biochemical Assessment of Porcine Hearts After Simulated Donation After Circulatory Death
2015
-
HeartWare HVAD for the Treatment of Patients With Advanced Heart Failure Ineligible for Cardiac Transplantation: Results of the ENDURANCE Destination Therapy Trial
2015
-
High Early Event Rates in Patients With Questionable Eligibility for Advanced Heart Failure Therapies
2015
-
IL-17 Mediates Post-Transplant Airway and Parenchymal Lung Fibrosis
2015
-
Impact of Repeated Mismatch Human Leukocyte Antigen on the Outcome of Lung Retransplantation
2015
-
Large Airway Oximetry and Hypoxia Related Gene Expression in Bronchial Epithelium in Early Post-Lung Transplantation
2015
-
Late Right Heart Failure Is Associated With Reduced Quality of Life and Functional Capacity in Continuous-Flow Left Ventricular Assist Device Recipients
2015
-
Late Right Heart Failure in Destination Therapy Patients With HeartMate II Continuous Flow Device
2015
-
Long Term Survival in Continuous Flow Left Ventricular Assist Devices
2015
-
Longer Waiting Time Increases Mortality in Heart Transplantation: An Instrumental Variable Analysis
2015
-
Survival After Lung Transplant in Alpha-1-Antitrypsin Deficiency Recipients Compared to Other Forms of Chronic Obstructive Pulmonary Disease
2015
-
Update on Post-Approval INTERMACs Registry of the HVAD System in Commercial Use
2015
-
Acute Rejection and Graft Failure Drive Worse Outcomes Among Peripartum Cardiomyopathy (PPCM) Patients Undergoing Heart Transplant (HT) in the US: A UNOS Analysis
2014
-
Cardiac Arrest in the Era of Mechanical Circulatory Support: A Single Center Experience with Extracorporeal Cardiopulmonary Resuscitation
2014
-
Cryoanalgesia Complements Thoracic Epidural Use Following Lung Transplantation
2014
-
Donor Diabetes and Lung Transplant: Does It Matter?
2014
-
Donor and Recipient Hepatitis C Status in Lung Transplant
2014
-
Echocardiographic Features and Utility of Baseline Echo in the Assessment of Pulmonary Hypertension in Patients with Atrial Septal Defect
2014
-
Elevated Hyaluronan Is Associated with Bronchiolitis Obliterans Syndrome
2014
-
First Report of the PAS INTERMACs Registry of the HVAD in Commercial Use
2014
-
Heart Transplantation for Myocarditis: Outcomes and Survival in a National Cohort
2014
-
Is a Priori Staging of Bilateral Lung Transplant the Optimal Surgical Approach for High-risk Patients With Interstitial Lung Disease?
2014
-
Partial Flow with 15F Arterial Cannula Provides Sufficient Circulatory Support in Veno-Arterial Extracorporeal Membrane Oxygenation
2014
-
Perioperative Venous Thromboembolism Prophylaxis in Lung Transplant Patients
2014
-
Plasma Lipid Peroxidation Products Are Higher in Lung Transplant Recipients with PGD and Are Associated with Donor Smoking
2014
-
Pre-Heart Transplant Recipient Counterpulsation Influences Primary Graft Dysfunction But Not Survival: Analysis of a National Cohort
2014
-
Supplementation of Hypogammaglobulinemia in Lung Transplant Recipients Leads to Favorable Outcomes
2014
-
The Columbia Experience of 163 Patients with Venoarterial Extracorporeal Membranous Oxygenation for Refractory Cardiogenic Shock
2014
-
The Utility of Pulmonary Function Tests in Predicting Pulmonary Outcomes Following Destination Therapy Left Ventricular Assist Device Placement
2014
-
What Your Lung Transplant Candidates with Chronic Obstructive Pulmonary Disease (COPD) Want and Expect from Transplant
2014
-
Whole Exome Sequencing: A Novel Strategy to Understand Chronic Lung Allograft Dysfunction (CLAD)
2014
-
Alternative Approaches for the Surgical Treatment of Significant Mitral Regurgitation in Advanced Heart Failure
2013
-
Antibody Directed Therapy after Lung Transplant
2013
-
Centers for Disease Control ‘High-Risk’ Donors and Thoracic Organ Transplantation: Expanding the Donor Pool
2013
-
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
2013
-
Do Donor Characteristics Matter? Prediction of Graft Utilization and Recipient Outcomes after Heart Transplantation
2013
-
Dynamic Changes in Dominant Antigen Responses Following Primary CMV Infection in Lung Transplant Recipients
2013
-
Mortality Differences after Heart Transplantation in Patients Bridged with Balloon Pumps vs. Left Ventricular Assist Devices
2013
-
Optimizing the Estimation of Renal Function in Lung Transplant Candidates
2013
-
Plasma Free Hemoglobin Potentiates the Association between Reperfusion FiO2 and Primary Graft Dysfunction after Lung Transplantation
2013
-
Plasma PAI-1 Used as a Quantitative Trait Implicates the Innate Immune Regulator TOLLIP in Post Lung Transplant Primary Graft Dysfunction Risk
2013
-
Right Atrial to Pulmonary Capillary Wedge Pressure Ratio Is Not Associated with Failure of Optimal Medical Management in the INTERMACS 4-5 Population
2013
-
Socioeconomic Disparities Associated with Medication Non-Adherence Following Lung Transplantation in Adult Recipients
2013
-
T Cell-Deficiency Exacerbates Diacetyl-Induced Obliterative Bronchiolitis
2013
-
The Characteristics and Outcomes of Advanced Heart Failure Patients with Hemodynamic Parameters Predictive of Right Ventricular Failure
2013
-
Utility of Six-Minute Walk Distance in Predicting Outcomes after Lung Transplant: A Nationwide Survival Analysis
2013
-
130 Extended Criteria Cardiac Transplantation Versus Destination Therapy Left Ventricular Assist Device Therapy in the Continuous Flow Era
2012
-
133 Cardiac Allograft Vasculopathy (CAV) in Children: An 18 Year Pediatric Heart Transplant Study (PHTS) Analysis in 3120 Patients
2012
-
149 Ambulatory ECMO Provides a Superior Bridge to Lung Transplantation Compared to Conventional ECMO
2012
-
155 Could Health Care Reform Reduce the Gap in Racial Disparities in Pulmonary Hypertension Outcomes?
2012
-
18 Prolonged Ischemic Time Exacerbates the Development of Chronic Gastric Fluid Aspiration-Associated Bronchiolitis Obliterans in Rat Pulmonary Allografts
2012
-
186 Long Term Mechanical Circulatory Support: What Are the Final Options?
2012
-
209 Functional TLR4 Polymorphisms Are Associated with Lower Risk of Primary Graft Dysfunction (PGD) after Lung Transplantation
2012
-
216 Right Ventricular Size and Function and Its Change over Time Independently Predict Survival in Pulmonary Hypertension
2012
-
276 Paired Donor Lung Expression Suggest Key Effectors in Primary Graft Dysfunction
2012
-
306 Concomitant Tricuspid Valve Procedure Reduces Right Ventricular Failure after Continuous Flow Left Ventricular Assist Device (LVAD) Implantation
2012
-
401 Differential Distribution and Functional Quality of CMV-Specific T Cell Effector Memory in High-Risk Lung Transplant Recipients
2012
-
521 Does Pulmonary Hypertension Preclude or Impact Outcomes in Single Lung Transplantations for Pulmonary Fibrosis in the Older Recipients
2012
-
71 Heparin May Not Be Needed as a Transition to Long Term Warfarin Therapy in LVAD Destination Therapy Patients
2012
-
717 Increased Distal Airway Nitric Oxide (NO) Release during Acute Complications in Lung Transplant Recipients (LTxR)
2012
-
767 Impact of Left Ventricular Assist Device Implantation upon Native Aortic Valve Regurgitation
2012
-
85 Lung Transplantation Is an Effective Treatment Option for Patients over the Age of 70
2012
-
9 Outcomes in Destination Therapy VAD and Extended Criteria Cardiac Transplantation Stratified by HeartMate Risk Score
2012
-
101 Infections after Surgery for Advanced Heart Failure: Experience of the NIH CT Surgical Trials Network
2011
-
178 Risk of Bleeding and Stroke in 700 HeartMate II LVAD Outpatients
2011
-
404 Differential Phenotype and Distribution of CMV-Specific T Cell Effector Memory between the Lung Allograft and Blood in High-Risk Lung Transplant Recipients
2011
-
42 The Importance of Low-Titer Anti-HLA Antibodies in Cardiac Transplantation
2011
-
46 Temporal Trends in the Prevalence of Primary Graft Dysfunction after Lung Transplantation in the Lung Transplant Outcomes Group (LTOG) Cohort
2011
-
Reduced Lifetime Incidence of Cytomegalovirus with Extended Prophylaxis: Long-Term Follow Up from a Randomized Controlled Trial
2011
-
115: Successful Lung Transplant Outcomes with “High Risk Donors”
2010
-
138: Neurocognitive Evaluation of Destination Therapy Pateints Receiving Continuous Flow Left Ventricular Assist Devices
2010
-
141: Infection during Mechanical Circulatory Support: Can We Really Expect a Better Outlook with Continuous Flow Technology
2010
-
150: Flow Cytometric Parameters of CD8 Lavage Cells in Detection of Acute Cellular Rejection in Lung Transplant
2010
-
175: Highly Sensitized LVAD Patients Can Be Safely Transplanted with Non-Crossmatched Hearts Using Plasmapheresis and Alemtuzumab: A Contemporaneous Case-Control Series
2010
-
186: CD8+ pp65-Specific T Cell Responses and T-Bet Levels Predict Relapsing Viremia Following Primary CMV Infection in Lung Transplant Recipients
2010
-
25: Donor Specific Antibody (DSA) as a Time Dependent Predictor Shows a Significant Negative Impact on Survival in Lung Recipients (Recips) Regardless of Pretransplant (Pretx) Antibody (Ab) Status
2010
-
34: Post Lung Transplant Peak Allograft Function Predictors. A Regression Model
2010
-
487: Alemtuzumab, a Promising Tool in the Rescue Armamentarium for Refractory Allograft Dysfunction with Cardiogenic Shock: Experience from a Single-Institution
2010
-
66: Destination Therapy: Improving Outcomes with Continuous Flow LVADs
2010
-
283: Post Transplant Survival Following Support with a Continuous Flow Left Ventricular Assist Device
2009
-
416: Adverse Event (AE) Rates in Patients Receiving Pulsatile VAD's: Incidence and Composition Change Dramatically 3 Months after Implant
2009
-
455: Surgical Repair of Gastroesophageal Reflux in Lung Transplant Recipients Is Associated with Decreased Armed Effector T Cells and Increased Exhausted T Cells within the Allograft
2009
-
51: Successful Management of Pump Pocket Infections in Patients with Implanted Left Ventricular Assist Devices
2009
-
539: Striking Expansion and Persistence of T-bet+CD8+ CMV-Specific T Cells with Primary Infection in Lung Transplant Recipients
2009
-
541: Increased CMV-Specific CD8+ Effectors and Viral Loads in the Lung Allograft Predict Viral Pneumonitis during Primary Infection
2009
-
54: Bleeding and Thromboembloic Complications with Pulsatile Versus Non-Pulsatile LVADs
2009
-
557: Immunosuppressive Intensity Should Be Reduced in Heart Transplant Recipients Greater Than 70 Years of Age
2009
-
596: An Increasing Percentage of Orthotopic Heart Transplant Procedures in the United States Are Being Performed at Lower-Volume Centers
2009
-
119: Dissecting CMV-Specific Immunity in High-Risk Lung Transplant Recipients: Differences between the Lung Allograft and Blood Effector Memory T Cells
2008
-
180: Early Fundoplication Reduces the Incidence of Chronic Allograft Dysfunction in Patients with Gastroesophageal Reflux Disease
2008
-
203: Right Ventricular Failure (RVF) in Patients with Continuous Flow Left Ventricular Assist Devices (LVAD)
2008
-
115: Aprotinin use and primary allograft dysfunction following off-pump bilateral orthotopic lung transplantation
2007
-
157: Perioperative predictors of renal failure following off-pump primary double lung transplantation
2007
-
240: Acquisition of CMV-specific CD8+ T cell memory during primary CMV infection in lung transplant recipients
2007
-
380: Chronic aspiration in lung allotransplantation induces a donor-specific hyperimmune state
2007
-
434: Infections in alternate versus standard list heart transplant patients: Implications for immunosuppression
2007
-
52: Non-hypoxic ischemia: An accurate cell culture model of ischemia reperfusion injury in lung transplantation
2007
-
241
2006
-
247
2006
-
251
2006
-
305
2006
-
Differences in survival and de novo anti-donor antibody development among lung transplant recipients presensitized to third party class I and class II HLA antigens
2005
-
Hoping for the best while preparing for the worst: Communication about end-of-life planning in Heart Transplant Programs
2005
-
Improved results treating primary lung allograft failure using veno-venous Extracorporeal Membrane Oxygenation (ECMO)
2005
-
Mortality associated with use of hepatitis C positive donors in alternate list heart transplantation
2005
-
Outcomes of an alternate list strategy for heart transplantation
2005
-
Rabbit antithymocyte globulin induction therapy for lung transplantation does not affect long-term allograft function or survival
2005
-
Maximizing use of organs recovered from the cadaver donor: Cardiac recommendations
2002
-
Anti-reflux surgery improves pulmonary function in lung transplant patients
2002
-
Heart transplantation in neonates and in children.
1992